Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Sunday, April 28, 2024 · 707,161,599 Articles · 3+ Million Readers

Musculoskeletal Diseases Treatment Market Growing at a Rapid Pace by 2025, at a CAGR of 5.3%

Arthritis Segment is expected to grow the Market for Musculoskeletal Diseases Treatment over the Forecast Period for Disease Segment.

NEW YORK, UNITED STATES, December 6, 2022 /EINPresswire.com/ -- The market for musculoskeletal diseases treatment is expected to grow due to rising prevalence of musculoskeletal disorders, increasing elderly population, and technological advancements in musculoskeletal disease diagnosis are boosting the market over the years. In addition, the development of hybrid diagnostic systems are likely to have a positive impact on the growth of the market in the coming years.

The global musculoskeletal diseases treatment market is expected to reach US$ 5,730.8 Mn in 2025 from US$ 3,837.9 Mn in 2017. The musculoskeletal diseases treatment market is estimated to grow with a CAGR of 5.3% from 2018-2025.

Get Sample Copy with Complete TOC and Figures & Graphs @ https://www.theinsightpartners.com/sample/TIPMD00002090/

Global musculoskeletal diseases treatment market, based on the disease into arthritis, osteoarthritis, osteoporosis, spondylitis, and others. The arthritis is the largest segment among the disease segment in the musculoskeletal diseases treatment market in 2017 and is also anticipated to hold the largest market in the year 2025 owing to the increasing prevalence of the disease and the higher acceptance of the population for the MRI for the diagnosis. However, the spondylitis segment is fastest growing segment and is accounted to grow at the highest CAGR during the forecast period.

The major players operating in the musculoskeletal diseases treatment market include General Electric, Koninklijke Philips N.V., Siemens AG, Canon Medical Systems Corporation, Hitachi, Ltd., Accuray Incorporated, MR Solutions, Alltech Medical Systems, Terason Division Teratech Corporation, and Echo-Son SA. For instance, in September 2018, Royal Philips launched the Ingenia Ambition X 1.5T MR. The product is the latest advance in the Ingenia MRI portfolio, that comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis. The developments performed by the companies are helping the market to grow in the coming years.

The report segments the global musculoskeletal diseases treatment market as follows:

Global Musculoskeletal Diseases Treatment Market – By Disease

Arthritis
Osteoarthritis
Osteoporosis
Spondylitis
Others

Global Musculoskeletal Diseases Treatment Market – By Imaging Modality

Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Ultrasound
Others

Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPMD00002090/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

Sameer Joshi
The Insight Partners
+ +91 96661 11581
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release